Global Helicobacter Pylori Invasive Testing Market Growth (Status and Outlook) 2025-2031

The global Helicobacter Pylori Invasive Testing market size is predicted to grow from US$ 246 million in 2025 to US$ 370 million in 2031; it is expected to grow at a CAGR of 7.1% from 2025 to 2031.

Helicobacter pylori is a type of bacteria that is known to be a major cause of peptic ulcers, which are sores on the lining of the esophagus, stomach or small intestine. H. pylori testing detects an infection of the digestive tract caused by the bacteria to help diagnose the cause of symptoms and/or ulcers.



H. pylori infections of the digestive tract are very common, with as many as half of the world’s population infected. However, most people with H. pylori never have any symptoms. Still, H. pylori infection increases the risk of developing ulcers (peptic ulcer disease), persistent stomach inflammation (gastritis), and gastric (stomach) cancer. The bacteria decrease the stomach’s ability to produce mucus, making the stomach prone to damage from digestive acid and peptic ulcers.

The growth of Helicobacter pylori (H. pylori) cases is increasing due to factors such as an increase in the number of infectious disease cases. Helicobacter pylori (H. pylori) is a bacterium that infects the stomach and is associated with a variety of gastrointestinal diseases, such as peptic ulcer disease and gastritis. There are several ways to diagnose H. pylori infection, such as respiratory, fecal antigen, and rapid urease tests. Helicobacter pylori is a bacterium that can infect the stomach and small intestine. It is a common bacterial infection that affects an estimated two-thirds of the world"s population. In rare cases, H. pylori can cause a variety of gastrointestinal problems, including gastritis (inflammation of the stomach wall), peptic ulcers (stomach or duodenal ulcers), and even stomach cancer. Common symptoms of H. pylori infection include abdominal pain, nausea, vomiting, loss of appetite and weight loss.

LPI (LP Information)' newest research report, the “Helicobacter Pylori Invasive Testing Industry Forecast” looks at past sales and reviews total world Helicobacter Pylori Invasive Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Helicobacter Pylori Invasive Testing sales for 2025 through 2031. With Helicobacter Pylori Invasive Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Helicobacter Pylori Invasive Testing industry.

This Insight Report provides a comprehensive analysis of the global Helicobacter Pylori Invasive Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Helicobacter Pylori Invasive Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Helicobacter Pylori Invasive Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Helicobacter Pylori Invasive Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Helicobacter Pylori Invasive Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Helicobacter Pylori Invasive Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Histology
Rapid Urease Test (RUT)
HP Culture

Segmentation by Application:
Hospitals
Clinics
Diagnostic Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Sekisui Diagnostics
F. Hoffmann-La Roche
Medline Industries
Meridian Bioscience
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Quidel
Halyard Health, Inc
Cardinal Health
Beckman Coulter Inc
Agilent Technologies
Coris BioConcept

Please note: The report will take approximately 2 business days to prepare and deliver.